Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol IR for Acute Pain from Bunionectomy (Bridging Study)
NCT01516008Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tapentadol in acute pain, sponsored by Janssen Pharmaceutical. Started Jan 2012; status: completed.
02
Drugs
tapentadol
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT01516008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01516008.